• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PERFUSION SYSTEMS EOPA ARTERIAL CANNULA; CATHETER, CANNULA AND TUBING, VASCULAR, CARDIO

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PERFUSION SYSTEMS EOPA ARTERIAL CANNULA; CATHETER, CANNULA AND TUBING, VASCULAR, CARDIO Back to Search Results
Model Number 77418
Device Problem Malposition of Device (2616)
Patient Problems Stroke/CVA (1770); Vascular Dissection (3160); Thrombosis/Thrombus (4440)
Event Date 11/19/2020
Event Type  Injury  
Manufacturer Narrative
Medtronic investigation: medtronic cannot confirm or deny the complaint of the type b aortic dissection, cerebral infarct and thrombotic cast during use as no product has been returned to date.A root cause of this occurrence cannot be determined without returned product, however, there is a possibility the adverse effects were caused during atraumatic placement of the cannula.Based on the instructions for use (ifu) this product is not intended to be used for ecmo (intended to be used less than 6 hours), and is not intended to be placed in the descending aorta, as was the placement in the literature article.The literature article does not identify any device malfunctions associated with the cannula.The device history record could not be reviewed as no lot number was provided.Complaints received for similar model numbers were reviewed and showed no trends warranting escalation related to this occurrence.The investigation was completed with the information that was provided, if additional information is received, the complaint file will be reopened if deemed necessary.If the product is returned, this pe will be reopened and the analysis and investigation will be updated.Medtronic will continue to monitor for future occurrences and trends.Citation: fukunaga et al.Descending aortic thrombosis and acute type b dissection during central extracorporeal membrane oxygenation: a word of caution.Jtcvs techniques 2021;6:85-7.Doi: org/10.1016/j.Xjtc.2020.11.006 epub 2020 nov 19.Date of publish used for date of event.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether this event has been previously reported.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information via literature regarding a case of simultaneous aortic thrombosis and acute type b aortic dissection (ad) caused by an arterial cannula placed in the descending aorta.All data were collected from a single center.A (b)(6) woman with a previous mitral commissurotomy via thoracotomy was admitted to another facility due to heart failure, sev ere mixed rheumatic mitral disease, and left ventricular ejection function of 45% with normal right ventricular function.Coronary angiography showed normal coronary arteries.The patient underwent redo mechanical mitral valve replacement and maze procedure for atrial fibrillation.At surgery, the right ventricle was lacerated on entry.The patient was sent to the intensive care unit with high-dose inotropic and vasopressor supports.The patient remained hemodynamically unstable and the next day was taken back to the operating room to relieve tamponade, and an intra-aortic balloon pump was inserted.Hemodynamic instability persisted; therefore, central veno-arterial extra corporeal membrane oxygenation (va-ecmo) was initiated with cannulas in the right atrium, ascending aorta, and right superiorpulmonary vein for venting.The patient¿s coronary arteries were reassessed and were widely patent.Transesophageal echocardiography showed no evidence of ascending or descending ad and thrombosis.The patient was transferred to toronto general hospital for ongoing care.Chest radiograph on arrival showed the tip of the aortic cannula in the descending aorta.The patient¿s heart improved and 6 days later she was successfully decannulated.The aortic eopa cannula had been placed in the distal ascending aorta and placed deeply to the transition zone so that the tip was indeed in the descending aorta.The cannulation technique and methods of confirmation of positioning performed at another hospital were not described in the article.While the patient was on ecmo, activated partial thromboplastin time was maintained between 40 and 60 seconds.Postoperatively, her creatinine rose from 92 to 280 mmol/dl.Transesophageal echocardiography revealed a thrombotic cast where the aortic cannula was along with an intimal flap suggestive of type b ad.Abdominal ultrasound confirmed that the intimal flap was confined to the thorax.Computed tomography was not used due to the elevated creatinine and further damage related to contrast.Computed tomography of the brain revealed a cerebral infarct in the posterior limb of the right middle cerebral artery without evidence of hemorrhage.Anticoagulation was initiated, and medical management for the type b ad was commenced.The patient was discharged from the hospital with normal cardiac, renal, and neurologic recovery.Based on the available information, the type b aortic dissection, cerebral infarct and thrombotic cast may have been attributed to the medtronic product no device malfunctions occurred.No additional adverse patient effects or product performance issues were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EOPA ARTERIAL CANNULA
Type of Device
CATHETER, CANNULA AND TUBING, VASCULAR, CARDIO
Manufacturer (Section D)
PERFUSION SYSTEMS
7611 northland dr
brooklyn park MN 55428
Manufacturer (Section G)
PERFUSION SYSTEMS
7611 northland dr
brooklyn park MN 55428
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
EI  
091708734
MDR Report Key12031377
MDR Text Key257128134
Report Number2184009-2021-00050
Device Sequence Number1
Product Code DWF
Combination Product (y/n)N
Reporter Country CodeCA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,literatur
Reporter Occupation Other
Type of Report Initial
Report Date 06/21/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number77418
Device Catalogue Number77418
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 05/26/2021
Initial Date FDA Received06/21/2021
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age49 YR
-
-